Riskpilot← Back to searchSign inGet full accessTORNEROSE BIO AS
ASActiveOrg 811626562Hoelveien 1, 1423 SkiLeasing of intellectual property and similar products, except copyrighted works · NACE 7740Est. 20130 employeeswww.biochos.com
Revenue 2024
NOK 0
EBITDA margin
—
-6% vs 2023
Equity ratio
7.8%
Financial strength
Net profit 2024
NOK 49K
+260% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -93K | -6% |
| Net profit | NOK 49K | +260% |
| Total assets | NOK 9,4M | +226% |
| Equity | NOK 734K | +7% |
| Employees | 0 | — |
Legal name
TORNEROSE BIO AS
Org number
811626562
Legal form
Aksjeselskap
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
9. mars 2013
Share capital
NOK 51 850
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Administrere avtalefestede fremtidige rettigheter på vegne av selskapets aksjonærer. Selskapet kan også eie aksjer i andre selskaper.
Address
Hoelveien 1, 1423 Ski
Website
www.biochos.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 714 | 286 | 1 172 | 1 019 | 2 781 | 2 119 | 966 | 2 544 | 7 | 21 806 | 0 | 0 |
| Staff expenses | −57 | −5 | −817 | −1 443 | −1 644 | −2 033 | −2 790 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 10 | −63 | 145 | −692 | 660 | −1 436 | −4 505 | −2 266 | −486 | 19 560 | −87 | −93 |
| Depreciation & amort. | −0 | −0 | −4 | −6 | −37 | −34 | −31 | −31 | −31 | −0 | −0 | −0 |
| EBIT | 10 | −63 | 141 | −698 | 622 | −1 470 | −4 536 | −2 297 | −517 | 19 560 | −87 | −93 |
| Net financials | 1 | 0 | 0 | −3 | 2 | 17 | 52 | −3 | −8 | 17 | 105 | 155 |
| Profit before tax | 11 | −63 | 141 | −701 | 624 | −1 452 | −4 484 | −2 300 | −525 | 19 578 | 17 | 62 |
| Tax | −0 | −16 | 6 | −385 | 97 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 11 | −47 | 135 | −316 | 527 | −1 452 | −4 484 | −2 300 | 1 407 | 15 271 | 14 | 49 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 86 | 24 | 2 763 | 2 721 | 3 222 | 6 920 | 2 450 | 2 062 | 3 271 | 2 879 | 2 883 | 9 412 |
| Equity | 30 | −17 | 2 618 | 2 302 | 2 829 | 6 201 | 1 717 | 1 167 | 2 574 | 672 | 686 | 734 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 402 | 2 190 | 2 194 | 2 208 |
| Short-term debt | 56 | 41 | 145 | 419 | 392 | 719 | 733 | 894 | 295 | 16 | 3 | 6 470 |
| Total debt | 56 | 41 | 145 | 419 | 392 | 719 | 733 | 894 | 697 | 2 207 | 2 197 | 8 678 |
EBITDA margin
-9251800.0%
This company
15.8%
Market median
-58555796% vs market
20132024
Equity ratio
7.8%
This company
38.2%
Market median
-80% vs market
20132024
Return on equity
6.6%
This company
18.4%
Market median
-64% vs market
20132024
Net profit margin
4870400.0%
This company
8.1%
Market median
+60128295% vs market
20132024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132024
Debt / equity
11.82×
This company
0.62×
Market median
-1806% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Akershus Teknologifond As | Company | 28.3% | 28.3% | 2024 |
| Individual | 17.7% | 17.7% | 2024 | |
| Individual | 15.1% | 15.1% | 2024 | |
Bvba K&E | Company | 13.1% | 13.1% | 2024 |
| Individual | 10.7% | 10.7% | 2024 | |
| Individual | 10.7% | 10.7% | 2022 | |
| Individual | 10.7% | 10.7% | 2024 | |
| Individual | 1.7% | 1.7% | 2024 | |
| Individual | 1.7% | 1.7% | 2022 | |
| Individual | 1.2% | 1.2% | 2024 | |
| Individual | 1.2% | 1.2% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TORNEROSE BIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Koen Roger Quaghebeur | Board of Directors | 0 companies |
| Christina Cecilie Hendrika Westerveld Haug | Chairman | 0 companies |
| Lars Gogstad | Board of Directors | 0 companies |